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Pharmacologic Manipulation of the Porcine Ureter:
Acute Impact of Topical Drugs on Ureteral Diameter
and Peristaltic Activity
CAROLINE D. AMES, M.D.,1 KYLE J. WELD, M.D.,1 STEPHEN T. DRYER, M.D.,1 GREG HRUBY, M.D.,1
SCOTT D. MINOR, M.D.,1 YAN YAN, M.D.,1 ROBERT S. FIGENSHAU, M.D.,1 SAM BHAYANI, M.D.,1
JAIME LANDMAN, M.D.,2 and RAMAKRISHNA VENKATESH, M.D.1

ABSTRACT
Background and Purpose: Intraluminal application of pharmacologic agents for acute ureteral dilation may
facilitate difficult ureteroscopy. We characterized the in-vivo effects of intraluminal application of verapamil
and theophylline on ureteral peristalsis and diameter in a porcine model.
Materials and Methods: Twenty-four female domestic pigs (35–40 kg) were incorporated into the study. We
deployed a giant magneto resistive (GMR) sensor and electromagnetic (EMG) electrodes laparoscopically onto
the ureteral surface for simultaneous measurement of the mechanical and electrical signals of ureteral peristalsis, respectively. The ureteral-luminal diameter was measured at three levels by digital retrograde pyelography and standardized to a 10-mm laparoscope. The results were calculated as change in peristalsis and
ureteral diameter from baseline during the first hour after drug injection. We tested two smooth-muscle relaxants, verapamil (2 mg/kg) and theophylline (70 mg/kg), with saline and dimethylsulfoxide (DMSO; solvent)
as controls. Six pigs were studied for each of the four groups. Hydration, anesthesia, and intra-abdominal
pressure were standardized. The serum concentrations of the drugs were measured to determine systemic absorption.
Results: During the first 10 minutes after intraluminal drug injection, theophylline caused a significant decrease in ureteral peristalsis (6.75 waves/10 minutes) compared with the control group (1.00/10 minutes; P 
0.02). This trend persisted for the next hour. However, there were no changes from baseline in ureteral width.
Ureteral peristalsis and dilation remained similar after the saline and DMSO injections. Verapamil increased
the diameter of the proximal ureter compared with the controls throughout the hour after drug injection. Fifteen minutes after the drug injection, the change in the ureteral diameter with verapamil was 1.38 mm (4.14F),
while the control group showed a change of 0.27 mm (P  0.03). At 1 hour, the width of the proximal ureter
in the verapamil group had increased by 1.72 mm (5.16F), while the control group had changed by 0.55 mm
(P  0.03). There were no statistically significant changes in the widths of the mid or distal ureter. No ureteral
dilation was observed in the other groups.
Conclusions: In the porcine model, intraluminal application of pharmacologic agents produced independent effects on ureteral dilation and peristalsis. Theophylline inhibited ureteral peristalsis, and verapamil produced acute proximal-ureteral dilation. The ability to alter ureteral diameter or peristaltic activity acutely
may facilitate ureteroscopy.
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INTRODUCTION

U

RETEROSCOPY has become a mainstay in the urologist’s
armamentarium for ureteral and renal collecting-system
access for both diagnostic and therapeutic purposes. Occasionally, ureteroscopy can be challenging in a nondilated ureter in
which the ureteroscope cannot be passed easily. The inability
to pass the ureteroscope may necessitate either acute dilation
of the ureter or short-term stenting before ureteroscopy.
Application of an intraluminal drug which, on contact with
the ureteral urothelium, causes acute dilation and relaxation of
the ureter without appreciable systemic effects may facilitate
ureteroscopic procedures and increase safety. In addition, relaxation of the ureter may facilitate the routine use of largerdiameter ureteroscopes, which would have greater deflection
and durability and a larger working channel. Acute dilation of
the ureter may also engender spontaneous passage of kidney
stones. Our primary goal was to evaluate pharmacologic agents
to determine if it is feasible to decrease ureteral smooth-muscle tone acutely when such drugs are applied intraluminally
within the ureter.
Studies to evaluate ureteral peristalsis have largely used endoluminal methods, employing either a pressure transducer1–4
or an ultrasound probe5 to evaluate ureteral physiology. However, these endoluminal devices can themselves alter ureteral
peristalsis, and, hence, intraluminal evaluation technologies
cannot be applied to measure ureteral peristalsis and the ureter’s
response to interventions such as stenting accurately.6 Previously, we reported the design, construction, and implementation of a novel extraluminal system to evaluate ureteral peristalsis.7 In this study, we utilized this system, which
incorporates electromyographic (EMG) and magnetic sensors,
for extraluminal evaluation of peristalsis in the porcine ureter.
This system is extraluminal and can be deployed using a minimally invasive (laparoscopic) technique to ensure minimal alteration of the ureteral anatomy and physiology.

MATERIALS AND METHODS
Animals and electromyography measurements
Permission for the study was obtained from the Washington
University Department of Comparative Medicine and the Washington University Animal Studies Committee. Twenty-four female domestic pigs (35–40 kg) were divided into four groups
of six animals each. Animals in group 1 received intraluminal
theophylline (70 mg/kg). Animals in group 2 received intraluminal verapamil (2 mg/kg). Groups 3 and 4 represented the control groups, with group 3 receiving 0.9% saline only and group
4 receiving dimethylsulfoxide (DMSO) (solvent) in either 1(N  3) or 2-mL (N  3) doses.
After a 16-hour fast but no fluid restriction, the pigs were anesthetized using xylazine, 0.45 mg/kg, and intubated and ventilated
using isoflurane anesthesia at a constant concentration of 2%. Intravenous yohimbine was used to reverse the effects of xylazine
soon after the insertion of trocars. Ketamine and atropine were not
used because of their known significant effects on ureteral peristalsis. The pig was hydrated with intravenous 5% glucose–0.45%
saline at a constant infusion rate of 5 mL/kg of body weight.

The electrical potentials from ureteral peristalsis were measured by two sets of modified bipolar steel wire EMG electrodes (Fig. 1). The bipolar wire electrodes were mounted on a
23-gauge, three-quarter-inch hypodermic needle to facilitate
laparoscopic deployment onto the serosal surface of the ureter.
The Teflon-coated wires from both electrodes led to two multipin connectors. The EMG signals from the electrodes were
amplified and displayed on a multichannel oscilloscope (Gould
1604; Gould Equipment, Ilsford, UK).
The mechanical movement of ureteral peristalsis was measured by the giant magneto resistance (GMR) sensor (Fig. 1).
The magnetic sensor technology consists of a 2  0.5-mm discshaped neodymium magnet that creates a magnetic field and a
GMR sensor (NVE Inc., Eden Prairie, MN), which identifies
any change in the magnetic field produced by movement of an
object placed within the field. The magnet is positioned, and a
small (4  4  0.75-mm) sensor plate is placed on the opposite side of the ureter. The GMR sensor was mounted on a custom-made aluminum strip for ease of laparoscopic deployment
and for accurate and atraumatic positioning under the ureter.
The sensor uses a Wheatstone bridge circuit, and the signals
from the sensor were amplified and displayed simultaneously
on the same oscilloscope with the EMG signals. This unique
sensor and its method of placement were developed in our laboratory and have been described.7

Operative technique
The pig was placed in a lateral decubitus position, and, using a three-port laparoscopic technique, the ureter was identified without any dissection. Pneumoperitoneum pressure was
maintained between 6 and 8 mm Hg to minimize the physiological effects. The peritoneum overlying the upper and mid
ureter was gently reflected medially to expose the surface of
the ureter.
After exposure of approximately 1 cm of the proximal ureter,
the baseline peristaltic rate was documented by laparoscopic visual observation for 5 to 10 minutes. Next, the EMG electrodes
and the magnetic sensor were deployed laparoscopically. The
first set of EMG electrodes was placed under the adventitia of
the ureter about 3 cm distal to the ureteropelvic junction, with
the hooks of the electrode wire facing the muscular surface.
Electrode positioning was achieved by inserting the needle
through the adventitia and then retracting it back over the wires,
leaving the tips of the wire electrodes on the ureteral surface.
The second set of EMG electrodes was placed approximately

FIG. 1. Experimental equipment. (A) Neodymium magnetic
disk and (B) GMR sensor. (C) and (D) Bipolar EMG wire electrodes mounted on hyperdermic needle.
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6 to 7 cm distal to the first set. A small (1-cm) window was
created under the ureter for placement of the magnet and the
magnetic sensor between the two sets of EMG electrodes. Care
was taken to preserve the ureteral blood supply to the extent
possible and to cause minimal disturbance of the in-situ ureter.
This arrangement of EMG leads provided good correlation with
endoscopically visible propagative peristaltic waves.
To deploy the GMR sensor, the small magnetic disc was
mounted on an applicator using K-Y jelly to keep it adherent
to the tip. The magnetic surface was coated with a thin layer
of fibrin glue and deployed on the anterior surface of the ureter.
The sensor was positioned under the posterior surface of the
ureter opposite the magnet. As the peristaltic wave propagated
along the ureter, the magnet on the ureteral surface moved in
relation to the sensor, and this movement produced a change in
the magnetic field, which was registered by the GMR sensor.
After the sensors were deployed, the intra-abdominal pressure was reduced to 5 mm Hg to lessen the effect that pneumoperitoneum might have on ureteral physiology. Baseline
peristalsis was measured for 1 hour. The GMR and EMG signals correlated with laparoscopically visible peristalsis. Intravenous hydration rate, intra-abdominal pneumoperitoneum
pressure, and anesthetic concentration were also documented
during the observation period. The rate and frequency of peristaltic waves were recorded.
A standardized retrograde pyelogram was performed by
passing a 5F open-ended ureteral catheter 2 cm into the distal
ureter under fluoroscopic guidance. The technique for each retrograde evaluation of the ureter was standardized by suspending a 200-mL bag of saline mixed with 60 mL of Conray
(Mallinckrodt Inc., Hazelwood, MO) 100 cm above the height
of the animal’s bladder. Diluted contrast medium was allowed
to fill the collecting system by gravity for exactly 60 seconds,
at which time, a fluoroscopic plain film was obtained during
the animal’s end-expiratory phase of ventilation. Precise digital measurements of the ureteral diameter were achieved using
OEC software at the proximal, mid, and distal levels to determine the diameter during a nonperistaltic phase (Fig. 2). This
method allows accurate measurement, up to 1/100 of a millimeter, with the digital fluoroscopy unit. The proximal-ureteral
measurement was made at the level of the lowest portion of the
ipsilateral lower-pole calix. The mid-ureteral measurement was
acquired at the upper border of the T12 vertebral body, and the
distal ureter was measured at the upper border of the S1 vertebral body. A GE-OEC series 9800 digital fluoroscopic unit (GE
OEC Medical Systems, Salt Lake City, UT) was utilized for all
experiments.

FIG. 2. Standardized retrograde pyelogram with digital measurements of proximal (P), mid (M), and distal (D) ureter.

The cystoscope was immediately placed gently against the
ureteral orifice to minimize leakage of the drug out of the orifice; and the catheter, capped by the empty syringe, was held
in the distal ureter over the next 15 minutes to keep the drug
from leaking out. Ureteral peristaltic activity was recorded for
10 minutes immediately after drug injection using the GMR and
EMG configuration described. Immediately after the 10-minute
recording, a Bentson wire was placed through the catheter to
the level of the distal ureter. The catheter was then removed,
allowing drainage of the pharmacologic agent out of the collecting system. Next, the ureteral catheter was replaced into the
distal ureter, and a standardized retrograde pyelogram was performed as previously described. The wire was replaced and the
catheter removed from the ureteral orifice to reduce the effect
the catheter might have on ureteral physiology.
Retrograde studies were procured at baseline and 15, 30, 45,
and 60 minutes after drug injection. Ureteral peristalsis was
measured at 10-minute intervals at baseline (before drug injection) and then at 0, 15, 30, 45, and 60 minutes postinjection.
The bladder remained decompressed with a Foley catheter
throughout the experiment. Serum drug concentrations were
measured at 15, 30, and 60 minutes after injection of each agent
to assess systemic absorption and effects. After the 60-minute
recordings, the animal was euthanized.

Statistical analysis
Experimental technique
Animals were then randomized into the four drug groups described previously. A retrograde pyelogram was obtained after 1
hour of baseline peristalsis monitoring. Next, 10 mL of the appropriate pharmacological agent was injected through the 5F
ureteral catheter over a period of 1 minute. Animals in group 1
received an average of 2.8 g of theophylline, and those in group
2 received 80 mg of verapamil. These dosages were chosen as
they were 10 times the normal systemic dose a human would receive. Each drug was dissolved in injectable saline, and 1 mL of
DMSO was added as a solvent, for a total volume of 10 mL.

Changes from baseline for both peristalsis and ureteral diameter were compared with the values in the control groups using the least-squares means procedure with Tukey-Kramer adjustment for multiple comparisons. Statistics were calculated
using SAS software (V. 9.0; SAS, Cary, NC).

RESULTS
A consistent correlation was found between laparoscopically
observed ureteral peristalsis and the peristalsis detected by the
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staltic rate (P  0.05) (Table 1; Fig. 3). There were no significant changes in ureteral diameter after theophylline injection
(Table 2). Serum theophylline concentrations averaged 8, 12,
and 20 g/mL at 15, 30, and 60 minutes, respectively. (Standard human therapeutic values are 10–20 g/mL) There were
no changes in blood pressure or heart rate after theophylline injection.

Verapamil

FIG. 3.

Immediately after intraluminal ureteral instillation, verapamil resulted in a significant increase in the number of peristaltic waves, from 4.00/10 minutes to 10.83/10 minutes. The
saline control group manifested no change in peristaltic rate
(P  0.03) (Fig. 3). Intraluminal verapamil administration produced a significantly larger proximal-ureteral diameter at 15
and 60 minutes (Fig. 4). At 15 minutes, the proximal ureter in
the verapamil group had changed from a mean diameter of 7.10
mm to 8.48 mm (increase of 1.38 mm or 4.14F) (P  0.03),
whereas the saline control group did not manifest a significant
change. At 60 minutes, the proximal ureter in the verapamil
group had changed from a diameter of 7.10 mm to 8.82 mm
(increase of 1.72 mm or 5.16F) (P  0.03). There was no
change in the ureteral diameter of the saline control group
(Table 2). There were no significant changes in the mid- or distal-ureteral diameters.
Serum verapamil concentrations averaged 30, 35, and 43
ng/mL at 15, 30, and 60 minutes and thus were below standard
human therapeutic serum values, which range from 50 to 100
ng/mL. At the 30-minute point, animals in the verapamil group
experienced a significant decrease in systolic blood pressure,
from 98.17 mm Hg to 75.33 mm Hg (P  0.03). There was no
significant change in diastolic blood pressure or heart rate.

Ureteral peristalsis after drug injection.

EMG electrodes and the magnetic sensor. The EMG action potentials were characterized by multiphasic bipolar spike potentials with rapid onset and return to the baseline. The signals
from the magnetic sensor were characterized as unipolar smooth
deflection and bell shaped. The EMG activity preceded the mechanical activity recorded by the magnetic sensor by a few milliseconds. The propagative peristaltic wave seen visually was
correlated with the proximal EMG, the GMR sensor, and the
distal EMG signals on the oscilloscope. There was no change
in the endoscopically visible baseline peristalsis before and after deployment of the EMG electrodes and the magnetic sensor device, indicating that deployment of the devices themselves
did not affect peristalsis.

DISCUSSION
Several studies have examined the effects of various pharmacologic agents on ureteral motility. Previous studies have
suggested that both theophylline and calcium-channel blockers
(CCB) such as verapamil may be instrumental in inhibition of
ureteral peristalsis.1,2,8–11
Theophylline has been found to decrease ureteral contractility when applied systemically in an in-vivo canine model1,2 and
in an in-vitro setting when applied to isolated guinea pig ureters
in a bath of modified Krebs solution.8 To our knowledge, ours
is the first study to quantitate changes in ureteral diameter in
response to pharmacologic manipulation in an in-vivo setting.

Theophylline
Immediately after intraluminal theophylline injection, peristaltic activity decreased from a baseline of 6.75/10 minutes to
1.00/10 minutes. In contrast, the saline control group manifested
no change in the rate of peristaltic activity (P  0.02). The trend
to decreased peristalsis continued for the next hour after theophylline injection. This was also statistically significant at 30
minutes, when the number of waves was decreased from
6.75/10 minutes to 0.83/10 minutes. At the 30-minute point, the
saline control group demonstrated no significant change in peri-

TABLE 1. CHANGE

Theophylline
Verapamil
Saline
DMSO
aP

IN

URETERAL PERISTALSIS

AFTER INJECTION OF

PHARMACOLOGIC AGENT

10 min

25 min

40 min

55 min

70 min

5.75a
6.83a
0.70
0.58

4.58
0.50
1.90
4.08

5.92
0.67
2.70
1.25

5.58
0.67
1.70
1.92

5.42
1.33
4.50
0.58

 0.05 compared with saline-treated control.
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FIG. 4.

structed as well as obstructed ureter.4 In these studies, the pharmacologic agents were administered systemically1,2 or applied
topically by dripping the agent into the ureteral lumen through
a catheter.12,13 To date, the in-vitro models described have utilized muscle baths to evaluate ureteral physiology.14,16–18 An
interesting approach to the evaluation of ureteral muscle tone
has been described by Miyatake and associates,19 who described
a model in which the force required to pull a glass bead through
short piece of rabbit ureter was measured before and after application of pharmacologic agents. In this model, less force was
required to pull the bead through the ureter after application of
isoproterenol compared with a control ureter.
Our model incorporating the extraluminal EMG and GMR
technologies has some advantages over previously described
techniques for ureteral physiological evaluation. In many contemporary in-vivo studies, the authors use an intraluminal pressure transducer to measure ureteral contractions.12,13 However,
the intraluminal transducer itself may result in artefactual results that affect ureteral motility.
A significant issue in the evaluation of pharmacologic manipulation of the ureter is the potential for adverse reactions
from systemic absorption. Both Danuser and associates16 and
Hauser and colleagues17 showed that topical phenylephrine administration within the ureter in an anesthetized pig model produces a local effect on the ureter without the systemic side effects seen when the same drug is given intravenously. These
groups used a 6F dual-lumen catheter placed through the renal
pelvis and into the ureter. One lumen was used for topical drug
administration and the other for recording of ureteral contractions by pressure transducer.
We used topical administration of the pharmacologic agents
and saw minimal systemic absorption. One group (verapamil)
had a drop in systolic blood pressure 30 minutes after drug administration. In this study, we used dosages approximately 10
times the oral (systemic) dose by intraluminal administration
on the basis of our clinical suspicion, as there are no data in
the literature to suggest the appropriate dose. Serum drug concentrations were carefully monitored, and although there was
some systemic absorption, the serum values remained within
human therapeutic limits. Certainly, future clinical trials will
have to consider the systemic effects of the pharmacologic
agents applied in regard to patient selection, intraoperative monitoring, and postoperative care.
Our study demonstrates a new method of studying ureteral
physiology using a unique, laparoscopically deployable extraluminal method. The GMR sensor is sensitive to small changes
in the magnetic field and allows accurate measurement of displacements of an object in linear, radial, and rotational systems.

Proximal ureteral diameter after drug injection.

Several studies have shown the effect of verapamil and other
CCB of diminishing peristaltic activity when applied to human
and animal ureteral segments in vitro.9–11 Clinically, CCB may
facilitate stone passage through the ureter in both nonsurgical12,13 and post-SWL14 patients. Stower and colleagues15 administered intravenous verapamil in a nonanesthetized canine
model and found decreased ureteral peristalsis in one of five
dogs, but no effect in the remaining four. The current study
showed a temporary increase in ureteral peristalsis after verapamil exposure, with a quick return to baseline. The deviation
in our results from previous findings may be related to interspecies variability. Alternatively, the most reliable decrease in
peristaltic activity has been demonstrated in the in-vitro setting,
and verapamil may be unreliable in producing ureteral relaxation in the intact, in-vivo model. We are uncertain of the reason for the increase in contraction after verapamil administration in our present study. The study of ureteral smooth-muscle
pharmacology has been fraught with conflicting findings, possibly because of the many differences in experimental technique
and animal models and the lack of sensitive instrumentation.1
Many techniques for studying pharmacologic action on
ureteral physiology have been described. Investigators have
used in-vivo models with both unanesthetized15 and anesthetized12,13 animals. Also, studies have been done in the unobTABLE 2. CHANGE

IN

URETERAL DIAMETER

15 min

Theophylline
Verapamil
Saline
DMSO
aP

AFTER INJECTION OF

30 min

PHARMACOLOGIC AGENT

45 min

60 min

Prox

Mid

Distal

Prox

Mid

Distal

Prox

Mid

Distal

Prox

Mid

Distal

0.3
1.38a
0.24
0.28

0.18
0.57
0.34
0.12

0.12
0.27
0.10
0.07

0.8
1.48
0.20
0.06

0.53
0.28
0.43
0.20

0.05
0.25
0.08
0.27

0.82
1.17
0.28
0.44

0.14
0.43
0.50
0.24

0.38
0.02
0.36
0.13

0.27
1.72a
0.35
0.38

0.02
0.55
0.13
0.30

0.05
0.05
0.72
0.30

 0.05 compared with saline-treated control.
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This makes the GMR sensor applicable for measuring peristaltic
activity in a tubular structure. The technology is based on the
giant magneto-resistive phenomenon that is being used in the
automobile and aircraft industries for various purposes (e.g.,
throttle positioning, wheel-speed sensing). To our knowledge,
this is the only such application of GMR sensor technology in
a macro biological system and was first described by our laboratory.7
Our technique enabled us for the first time to evaluate the
acute effects of different smooth-muscle relaxants on ureteral
peristalsis. By using this extraluminal approach, we were able
to isolate drug effects, without the artifactual changes associated with intraluminal monitoring devices, which are known
to alter ureteral peristaltic activity. Additionally, we described the first standardized, digital retrograde urography
system to determine changes in ureteral diameter accurately
as a function of pharmacologic manipulation of in-vivo
ureteral physiology.
The use of minimally invasive techniques to study ureteral
physiology without placing an intraluminal catheter for measurements may help to reveal differences regarding ureteral
smooth-muscle response to pharmacologic agents.

CONCLUSIONS
The pharmacologic agents manifested independent effects on
ureteral dilation and peristalsis. Intraluminal ureteral theophylline administration caused acute inhibition in ureteral peristalsis with minor increases in serum concentrations and no significant change in ureteral diameter. Intraluminal ureteral
verapamil administration yielded significant acute proximal dilation. The ability to alter ureteral diameter or peristaltic activity or both acutely may have important clinical implications for
endoscopic interventions in the upper urinary tract.

ACKNOWLEDGMENT
We thank the Midwest Stone Institute (St. Louis, MO) for
providing a grant to help support this research study.

REFERENCES
1. Boatman DL, Lewin ML, Culp DA, Flocks RH. Pharmacologic
evaluation of ureteral smooth muscle: A technique for monitoring
ureteral peristalsis. Invest Urol 1967;4:509–520.
2. Wein AJ, Gregory JG, Sansone TC, Schoenberg HW. The effects
of aminophylline on ureteral and bladder contractility. Invest Urol
1972;9:290–293.
3. Roshani H, Dabhoiwals NF, Dijkhuis T, Pfaffendorf M, Boon TA,
Lamers WH. Pharmacological modulation of ureteral peristalsis in
a chronically instrumented conscious pig model I: Effect of cholinergic stimulation and inhibition. J Urol 2003;170:264–267.
4. Tomiyama Y, Wanajo, I, Yamazaki Y, Kojima M, Shibata N. Effects of cholinergic drugs on ureteral function in anesthetized dogs.
J Urol 2004;172:1520–1523.
5. Roshani H, Dabhoiwala NF, Dijhuis T, Kurth KH, Lamers WH.
An in vivo endoluminal ultrasonographic study of peristaltic activity in the distal porcine ureter. J Urol 2000;163:602.

6. Dale RL, Constantinou CE, Briggs EM, et al. Dynamics of the upper urinary tract: The effect of an indwelling ureteral catheter on
ureteral peristalsis. Invest Urol 1971;8:655.
7. Venkatesh R, Landman J, Minor SD, et al. Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: Initial studies using a novel implantable magnetic sensor. J Endourol
2005;19:170–176.
8. Bloch R, Decker N, Kostakopoulos A. Effects of theophylline and
isoproterenol on the activity on the isolated guinea pig ureter. Urol
Int 1984;39:308–311.
9. Golenhofen K, Lammel E. Selective suppression of some components of spontaneous activity in various types of smooth muscle
by Iproveratril (verapamil). Pflugers Arch Eur J Physiol 1972;
331:233–243.
10. Hertle L, Mawrath H. Calcium channel blockade in smooth muscle of the human upper urinary tract I: Effects on depolarizationinduced activation. J Urol 1984;132:1265–1269.
11. Maggi CA, Meli A. The effect of nifedipine and verapamil on KClinduced rhythmic contractions of guinea-pig ureter in vitro. Experientia 1984l40:681–686.
12. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of
nifedipine and deflazacort in the management of distal ureter
stones. Urology 2000;56:579–582.
13. Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quarantelli C, Mineo F. Nifedipine and methylprednisolone in facilitating
ureteral stone passage: A randomized, double-blind, placebo-controlled study. J Urol 1994;152:1095–1098.
14. Porpiglia F, Destefanis P, Fiori C, Scarpa RM, Fontana D. Role of
adjunctive medical therapy with nifedipine and deflazacort after
extracorporeal shock wave lithotripsy of ureteral stones. Urology
2002;59:835–838.
15. Stower MJ, Clark AG, Wright JW, Hardcastle JD. The effect of
various drugs on canine ureteric peristalsis. Urol Res 1986;14:
41–44.
16. Danuser H, Weiss, R, Abel D, Walter B, Scholtysik G, Mettler D,
Studer UE. Systemic and topical drug administration in the pig
ureter: Effect of phyosphodiesterase inhibitors a1,  and 2-adrenergic receptor agonists and antagonists on the frequency and
amplitude of ureteral contractions. J Urol 2001;166:714–720.
17. Hauser DS, Mevissen M, Weiss R, Portier CJ, Scholytsik G, Studer
UE, Danuser H. Effects of ketanserin and DOI on spontaneous and
5-HT-evoked peristalsis of the pig ureter in vivo. Br J Pharmacol
2002;135:1026–1032.
18. Cole RS, Fry CH, Shuttleworth KED. The action of the prostaglandins on isolated human ureteric smooth muscle. Br J Urol
1988;61:19–26.
19. Miyatake R, Tomiyama Y, Murakami M, Park Y, Kurita T. Effects
of isoproterenol and butyscopolamine on the friction between an
artificial stone and the intraureteral wall in anesthetized rabbits. J
Urol 2001;166:1083–1087.

Address reprint requests to:
Ramakrishna Venkatesh, M.D.
4960 Children’s Place
Campus Box 8242
St. Louis, MO 63110
E-mail: rvenkateshat@aol.com

ABBREVIATIONS USED
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